Literature DB >> 22311010

The indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review.

Jiexian Ma1, Min Wu.   

Abstract

To explore the relationship of Notch1 mutation in T-ALL with the survival rate of T-ALL patients. The PubMed database, the Cochrane Library, conference proceedings, EMBASE databases, and references of published trials and review articles were searched. Two reviewers independently assessed the quality of the trials and extracted data. Hazard ratios (HRs) for event-free survival (EFS) were pooled by STATA package. Seven trials involving 964 patients with T-ALL were ultimately analyzed. Seven hundred and eleven patients were children (age <18 years), 253 patients were adults (age ≥18 years). The pooled HR showed that Notch1 mutated group could not prolong EFS than Notch1 WT group both in children and adult patients. Although constitutively activated forms of the NOTCH1 receptor are potent inducers of T-ALL, our results suggest that Notch1 mutation could not become an indicator for EFS in T-ALL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311010     DOI: 10.1007/s11033-011-1424-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

1.  Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex.

Authors:  Christy J Fryer; Elise Lamar; Ivana Turbachova; Chris Kintner; Katherine A Jones
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

2.  FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.

Authors:  Myoung-Ja Park; Tomohiko Taki; Megumi Oda; Tomoyuki Watanabe; Keiko Yumura-Yagi; Ryoji Kobayashi; Nobuhiro Suzuki; Junichi Hara; Keizo Horibe; Yasuhide Hayashi
Journal:  Br J Haematol       Date:  2009-02-24       Impact factor: 6.998

Review 3.  Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.

Authors:  F M Uckun; M G Sensel; L Sun; P G Steinherz; M E Trigg; N A Heerema; H N Sather; G H Reaman; P S Gaynon
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

4.  The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.

Authors:  Alena Malyukova; Takeaki Dohda; Natalie von der Lehr; Shahab Akhoondi; Shahab Akhondi; Martin Corcoran; Mats Heyman; Charles Spruck; Dan Grandér; Urban Lendahl; Olle Sangfelt
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

Review 5.  Acute lymphoblastic leukemia.

Authors:  Dieter Hoelzer; Nicola Gökbuget; Oliver Ottmann; Ching-Hon Pui; Mary V Relling; Frederick R Appelbaum; Jacques J M van Dongen; Tomasz Szczepański
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

6.  Mastermind critically regulates Notch-mediated lymphoid cell fate decisions.

Authors:  Ivan Maillard; Andrew P Weng; Andrea C Carpenter; Carlos G Rodriguez; Hong Sai; Lanwei Xu; David Allman; Jon C Aster; Warren S Pear
Journal:  Blood       Date:  2004-06-08       Impact factor: 22.113

7.  TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Authors:  L W Ellisen; J Bird; D C West; A L Soreng; T C Reynolds; S D Smith; J Sklar
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

8.  The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.

Authors:  C Kox; M Zimmermann; M Stanulla; S Leible; M Schrappe; W-D Ludwig; R Koehler; G Tolle; O R Bandapalli; S Breit; M U Muckenthaler; A E Kulozik
Journal:  Leukemia       Date:  2010-10-14       Impact factor: 11.528

9.  The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  A Larson Gedman; Q Chen; S Kugel Desmoulin; Y Ge; K LaFiura; C L Haska; C Cherian; M Devidas; S B Linda; J W Taub; L H Matherly
Journal:  Leukemia       Date:  2009-04-02       Impact factor: 11.528

10.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.

Authors:  W S Pear; J C Aster; M L Scott; R P Hasserjian; B Soffer; J Sklar; D Baltimore
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  5 in total

1.  [The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia].

Authors:  S S Guo; J Q Mi; J Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-02-14

2.  Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.

Authors:  Tasneem Khanam; Sarah Sandmann; Jochen Seggewiss; Charlotte Ruether; Martin Zimmermann; Allison B Norvil; Christoph Bartenhagen; Gerrit Randau; Stephanie Mueller; Heidi Herbrueggen; Per Hoffmann; Stefan Herms; Lanying Wei; Marius Woeste; Christian Wuensch; Humaira Gowher; Ilske Oschlies; Wolfram Klapper; Wilhelm Woessmann; Martin Dugas; Birgit Burkhardt
Journal:  Blood       Date:  2021-04-29       Impact factor: 22.113

3.  Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia.

Authors:  Magnus Borssén; Lars Palmqvist; Kristina Karrman; Jonas Abrahamsson; Mikael Behrendtz; Jesper Heldrup; Erik Forestier; Göran Roos; Sofie Degerman
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

4.  Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia.

Authors:  Rong-Bin Liu; Jian-Gui Guo; Tian-Ze Liu; Cheng-Cheng Guo; Xin-Xiang Fan; Xiao Zhang; Wei-Han Hu; Xiu-Yu Cai
Journal:  Oncotarget       Date:  2017-06-19

5.  NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Shunsuke Kimura; Masafumi Seki; Kenichi Yoshida; Yuichi Shiraishi; Masaharu Akiyama; Katsuyoshi Koh; Toshihiko Imamura; Atsushi Manabe; Yasuhide Hayashi; Masao Kobayashi; Akira Oka; Satoru Miyano; Seishi Ogawa; Junko Takita
Journal:  Cancer Sci       Date:  2019-01-09       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.